Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1900 1
1966 1
2000 1
2001 1
2003 2
2005 1
2008 1
2009 2
2010 1
2011 4
2012 2
2013 2
2014 4
2015 5
2016 18
2017 15
2018 13
2019 7
2020 4
2021 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 29180056

82 results

Results by year

Filters applied: . Clear all
Page 1
Controversy and debate on dengue vaccine series-paper 2: response to review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs.
Hadinegoro SRS, Arredondo-García JL, Capeding MR, Pallardy S, Noriega F, Bouckenooghe A. Hadinegoro SRS, et al. J Clin Epidemiol. 2018 Mar;95:140-141. doi: 10.1016/j.jclinepi.2017.12.024. Epub 2018 Jan 3. J Clin Epidemiol. 2018. PMID: 29306062 No abstract available.
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease.
Hadinegoro SR, Arredondo-García JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, Muhammad Ismail HI, Reynales H, Limkittikul K, Rivera-Medina DM, Tran HN, Bouckenooghe A, Chansinghakul D, Cortés M, Fanouillere K, Forrat R, Frago C, Gailhardou S, Jackson N, Noriega F, Plennevaux E, Wartel TA, Zambrano B, Saville M; CYD-TDV Dengue Vaccine Working Group. Hadinegoro SR, et al. N Engl J Med. 2015 Sep 24;373(13):1195-206. doi: 10.1056/NEJMoa1506223. Epub 2015 Jul 27. N Engl J Med. 2015. PMID: 26214039 Free article. Clinical Trial.
[Analysis of the evidence on the efficacy and safety of CYD-TDV dengue vaccine and its potential licensing and implementation through Mexico's Universal Vaccination Program].
Hernández-Ávila M, Lazcano-Ponce E, Hernández-Ávila JE, Alpuche-Aranda CM, Rodríguez-López MH, García-García L, Madrid-Marina V, López Gatell-Ramírez H, Lanz-Mendoza H, Martínez-Barnetche J, Díaz-Ortega JL, Ángeles-Llerenas A, Barrientos-Gutiérrez T, Bautista-Arredondo S, Santos-Preciado JI. Hernández-Ávila M, et al. Salud Publica Mex. 2016 Jan-Feb;58(1):71-83. Salud Publica Mex. 2016. PMID: 26879510 Review. Spanish.
The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study.
Flasche S, Jit M, Rodríguez-Barraquer I, Coudeville L, Recker M, Koelle K, Milne G, Hladish TJ, Perkins TA, Cummings DA, Dorigatti I, Laydon DJ, España G, Kelso J, Longini I, Lourenco J, Pearson CA, Reiner RC, Mier-Y-Terán-Romero L, Vannice K, Ferguson N. Flasche S, et al. PLoS Med. 2016 Nov 29;13(11):e1002181. doi: 10.1371/journal.pmed.1002181. eCollection 2016 Nov. PLoS Med. 2016. PMID: 27898668 Free PMC article.
A review of Dengvaxia®: development to deployment.
Thomas SJ, Yoon IK. Thomas SJ, et al. Hum Vaccin Immunother. 2019;15(10):2295-2314. doi: 10.1080/21645515.2019.1658503. Epub 2019 Oct 7. Hum Vaccin Immunother. 2019. PMID: 31589551 Free PMC article. Review.
Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study.
Sáez-Llorens X, Tricou V, Yu D, Rivera L, Tuboi S, Garbes P, Borkowski A, Wallace D. Sáez-Llorens X, et al. Lancet Infect Dis. 2017 Jun;17(6):615-625. doi: 10.1016/S1473-3099(17)30166-4. Epub 2017 Mar 30. Lancet Infect Dis. 2017. PMID: 28365225 Clinical Trial.
82 results